Summary A hospital-based case-control study was conducted over 4 years in Southern France to assess the pattern of established risk factors for breast cancer and to examine its variation according to age at diagnosis. Cases studied (450) were women admitted to the Montpellier Cancer Institute, with histologically confirmed primary breast carcinoma. Controls (576) Different approaches can be taken to reconcile these discrepancies. A meta-analysis of several epidemiological data-sets, by increasing the power of study can detect effects which are not significant in a single study and show that these different results can be unified (Ewertz et al., 1990) . Another approach is to stratify by age at diagnosis, since BC appears to be different if diagnosed in young or in older women (de Waard, 1979) . A good example which shows that discrepancies lie more on age classes than on regional variations, is a study conducted in Canada. A first report did not disclose either a risk for nulliparity nor a protective effect for multiparity (Burns et al., 1981) , while a second analysis showed that in 45 and above years age group nulliparity was a strong risk factor (Lubin et al., 1982) .
Various risk factors for breast cancer (BC) have been recognised for many years. There is agreement by most authors on a list of 'established' (Kelsey & Gammon, 1990 ) risk factors, made up of reproductive and menstrual variables, socioeconomic status, family history of BC and previous benign breast disease. These have been found in most countries where studies have been conducted: North America (Helmrich et al., 1983; Lubin et al., 1987) ; Scandinavia (reviewed in Ewertz et al., 1990) ; Western Europe (Talamini et al., 1985; Le et al., 1984) ; Eastern Europe (Plesko et al., 1985) ; Asia (Thein & Theen et al., 1978) and South America (Mirra et al., 1971 ). However, in several studies, there is no risk increase associated with some of these established factors (Adami et al., 1980; East European Study of BC epidemiology, 1990) .
Different approaches can be taken to reconcile these discrepancies. A meta-analysis of several epidemiological data-sets, by increasing the power of study can detect effects which are not significant in a single study and show that these different results can be unified (Ewertz et al., 1990) . Another approach is to stratify by age at diagnosis, since BC appears to be different if diagnosed in young or in older women (de Waard, 1979) . A good example which shows that discrepancies lie more on age classes than on regional variations, is a study conducted in Canada. A first report did not disclose either a risk for nulliparity nor a protective effect for multiparity (Burns et al., 1981) , while a second analysis showed that in 45 and above years age group nulliparity was a strong risk factor (Lubin et al., 1982) .
The study of Quetelet index {weight (kg) << height2 (m)) as a risk factor for BC is another reason for presenting results by age-group, since this risk factor is usually found only in older women (Parazzini et al., 1990) .
The results presented here are part of a study carried out in Montpellier which focused essentially on nutritional factors in breast cancer and on related blood levels of liposoluble vitamins and lipid parameters (Gerber et al., 1988; Gerber et al., 1989; Richardson et al., 1989; Gerber et al., 1990; Cavallo et al., 1991; Gerber et al., 1991; .
The purpose of the present analysis was as follows: (i) Breslow and Day (1980) . Age at diagnosis was studied in three groups: under 45, 45-54 and 55 years old and over. To assess interaction with age at diagnosis and with menopausal status, chi-square tests of homogeneity were calculated following Breslow and Day (1980) . Confounding variables were evaluated by stratified techniques (Mantel-Haenzel), and are considered as relevant for adjustment if the OR for the factor being studied changes when allowance is made for the potential confounding factor. The multivariate analysis was carried out in each age-group via multiple logistic regression to simultaneously control for the potential confounders (Breslow & Day, 1980) . Allowance was made for factors only if they affected the risk estimates when included in the models generated by logistic regression. Few patients for whom in- There are significant interactions and trends in at least one stratum between age at diagnosis and age at menarche, age at diagnosis and familial history of BC, and a significant trend between age at diagnosis and a history of BBD (Table  III) .
When interaction with menopausal status has been analysed (Table IV) children seemed to have a protective role in the youngest and the oldest women. The ORs are non significant in both cases, but the trend is significant in the oldest group, giving more strength to this factor in this later group. On the contrary, a non significant detrimental effect of having two to three children is shown in the two youngest groups. The strong risk associated with having a first degree relative with BC increased with age at diagnosis after 45 years. However, if an upper limit of 40 years is selected for the youngest group an elevated OR is also found associated with the family history of BC (OR = 2.7, 2/38 cases against 1/52 controls). The risk associated with BBD (fibrocystic dystrophia) history is not significant in the older women group (>55). In the two youngest groups, the risk is statistically significant and increases with decreasing age at diagnosis. There is a nonsignificantly increased OR with an increasing Quetelet index in each age group except for the youngest one, who shows an OR above one only in the highest class. The values of the ORs increase with age for the same index class. The menopausal status could be analysed only in the intermediary group: premenopause is significantly associated with an elevated OR. This is in line with the increased risk associated with increasing age at menopause in the oldest group (OR and trend are significant).
Discussion
As in all hospital-based case-control studies, selection bias cannot be totally excluded. For example, one study reported that the use of hospital controls led to the exaggeration of the age at first birth effect and also that hospitalised women tend to have more children than women in the normal population (Lund, 1989) . In order to limit geographical bias, controls and patients were recruited from the same region . With regard to bias related to the diseases of controls, first, it can be said that as a whole the pathologies displayed in the control group are not linked to the established BC risk factors. Then, the controls being recruited in three wards with different specialisation covering a large range of pathologies, this should minimise an eventual bias linked to a specific pathology. Besides, there is an advantage of hospital based case-control studies: it is expected that they have similar motivation for answering since both cases and controls are patients in a hospital. In our total sample, the reproductive factors have shown the same pattern as that described in other populations all over the world (Helmrich et al., 1983; Lubin et al., 1982; Ewertz et al., 1990; Talamini et al., 1985; Le et al., 1984; Plesko et al., 1985; Thein-Hlaing et al., 1978; Mirra et al., 1971) . However, parity was not found completely in line with what has been generally reported, since have two or three children was associated with a somewhat elevated OR compared with having no child and have more than three children was not significantly associated with a protective effect. This has also been found by Boyle (1988) and Burns et al. (1981) .
The striking finding of our study is the age-specificity of the various risk factors for BC. This is shown both by the results of interaction tests and the variation of ORs across the three age groups. Although some interaction tests are not significant, it should be noted that these tests are not very powerful. Our strategy of not systematically adjusting for age but to consider first if age at diagnosis is an effect-modifier has been shown to be a relevant rationale. To be complete, interaction tests were also carried between menopausal status and the various risk factors. The menopausal status provides information on the hormal status of the subject and is of interest. However, because of the uncertainty related to the precise age and to the hormonal unbalance of the perimenopausal state, classes are partly inaccurate. The only clear indication brought up by the results in Table IV (Mirra et al., 1971; Ewertz & Duffy, 1988; Negri et al., 1990; Ewertz et al., 1990; Tulinius et al., 1990) . Although non statistically significant, our results suggest that having two or three children in young women at diagnosis is associated with greater risk. This has also been observed by Kvale et al. (1987); Negri et al. (1990) and Williams et al. (1990) . Since we do not have information about the date of the last pregnancy, we cannot say for sure that this increased risk is related to the detrimental effect of a recent pregnancy (Bruzzi et al., 1988) . However, it is very likely, because the increased risk is restricted to the youngest groups.
In the older groups, the risks were quite different. Age at natural menopause and family history of BC are significantly associated with BC. Having more than three children is associated with lower OR and there exists a significant trend of decreasing risk with increasing number of children. The OR for the highest class of Quetelet index is above one and higher than in the youngest age group. Obviously, menopause is an event occurring at the end of the reproductive life and multiparity as well as increased body mass index are generally concomittant to an older age. Thus, these risk factors for elderly women are events occurring late in life.
The question of a difference between BC in young and older women has often been evoked in the literature since the pioneer work of de Waard (1979) , which was extended later (Lubin et al., 1982; de Waard, 1988; Bouchardy, 1990) . This difference is generally associated with menopausal status. Our results suggest that the length of life elapsed before diagnosis may be a major determinant of which factors will be risk factors or not. This is generally true when considering risk factors which are dependent themselves upon the time of occurrence in life. If we assume that cancer initiation, induced by either an exogenous or endogenous exposure occurs early in life, one can reasonably expect that an early menarche which causes proliferation of susceptible cells will increase the risk of BC development. In the same line, an early first full term pregnancy which induces cell differentiation, thus decreasing susceptibility, will be protective. The aging of the breast tissue at menopause is a protective factor which will be effective in as much as it occurs close to cell transformation, that is to say near to the time of initiation. Thus, the somatic mutation leading to cancer induction would have occurred early in life in young BC cases and late in life, in elderly BC cases. Why this difference is generally associated with distinct prognostic features remains to be determined. It can be proposed that early induction carried an intrinsic tendency to aggressivity contrarily to late induction; alternatively, different clinic and prognostic features may result from the physiological status of the host: in young women oestrogens which are known as growth factors inducers, show higher levels than in older women. It should be noted that the only significant interaction with menopausal status (that is to say with active hormonal status) has been found with age at FFTP indicating that a late age at FFTP might be detrimental not only because breast tissue differentiation occurs late in life, but also because initiation occurs in a growth stimulating environment. Reciprocally, the cellular and metabolic properties of a senescent organism may be less facilitating for cell proliferation.
Our finding on a BC risk associated to family history seems to contradict our assumption. If familial BC are attributed to inheritance of dominant genes, one should expect to find this risk factor associated with BC in young women (Lynch & Watson, 1990) . Indeed, when examining under 40 year old women, we found an OR above two; however, other reports showed that this risk factor exists in older age groups (Burns et al., 1981; Mettlin et al., 1990 ). This suggests heterogeneity in familial cases as hypothesised by Andrieu et al. (1989) . One model of inheritance implies gene(s) with high penetrance in which environment should be less important. This model would be associated with BC risk at a young age. A second possible model assumes that one or several common alleles would increase sensitivity to environmental factors: this model would be associated with BC risk at an older age since a long period of time will allow for the effect of more endogenous and exogenous factors.
Our data suggest that if a woman with a fibrocystic dystrophia gets to over 55 years of age, there is no or little risk that BC develops. It can be said that this type of BBD is related to an elevated oestrogen synthesis which physiologically decreases at menopause. Thus this BBD may merely reflect an hyperoestrogenemia responsible for the increased risk. The alternative hypothesis would be a direct cellular effect of the histological alteration. One finding in our study remains without satisfactory explanation: a significantly high OR has been found associated with an age at menarche in the intermediary class (13-14) . Schatzkin et al. (1987) reported the same finding in a casecontrol study on black women in the USA and concluded that their results were inconsistent. Also, older women who do not remember their exact age at menarche may tend to give such ages, since they are the most frequent (recall bias).
In summary, in spite of certain limitations inherent in case-control studies and to the size of our population, our results suggest that most of BC risk factors are age-specific. This is consistent with the multistage theory of carcinogenesis, each factor playing a specific role in conjunction with the stage of development of cancer. Therefore to distinguish pre-and post-menopausal cancer is not as relevant as to describe BC risk factors in each age stratum.
